Zhende Medical Co Ltd (603301) — Capital Reinvestment Ratio
Zhende Medical Co Ltd (603301) has a Capital Reinvestment Ratio of 1.07x as of September 2025, meaning it reinvests 1% of its operating cash flow (CN¥101.93 Million) in capital expenditures (CN¥109.24 Million). See 603301 equity financing ratio to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Zhende Medical Co Ltd Capital Reinvestment Ratio (2014–2025)
This chart tracks Zhende Medical Co Ltd's Capital Reinvestment Ratio across 12 annual periods. Check Zhende Medical Co Ltd (603301) total reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Zhende Medical Co Ltd (2014–2025)
Year-by-year Capital Reinvestment Ratio for Zhende Medical Co Ltd from 2014 to 2025. For live market cap and broader valuation context, see Zhende Medical Co Ltd market capitalisation.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 1.02x | CN¥538.49 Million | CN¥550.22 Million | ▼ -38.8% |
| 2024 | 1.67x | CN¥461.14 Million | CN¥769.69 Million | ▲ +25.9% |
| 2023 | 1.33x | CN¥452.11 Million | CN¥599.24 Million | ▲ +119.0% |
| 2022 | 0.61x | CN¥1.25 Billion | CN¥754.12 Million | ▼ -28.8% |
| 2021 | 0.85x | CN¥817.63 Million | CN¥695.47 Million | ▲ +142.9% |
| 2020 | 0.35x | CN¥3.12 Billion | CN¥1.09 Billion | ▼ -74.7% |
| 2019 | 1.38x | CN¥197.76 Million | CN¥273.79 Million | ▼ -87.6% |
| 2018 | 11.20x | CN¥20.25 Million | CN¥226.70 Million | ▲ +1313.5% |
| 2017 | 0.79x | CN¥182.34 Million | CN¥144.45 Million | ▼ -31.1% |
| 2016 | 1.15x | CN¥138.57 Million | CN¥159.23 Million | ▲ +608.9% |
| 2015 | 0.16x | CN¥142.70 Million | CN¥23.13 Million | ▼ -76.6% |
| 2014 | 0.69x | CN¥83.63 Million | CN¥57.93 Million | — |